Martin Louis Wilson - 12 Aug 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
General Counsel
Signature
/s/ Martin Louis Wilson
Issuer symbol
RCKT
Transactions as of
12 Aug 2022
Net transactions value
$0
Form type
4
Filing time
16 Aug 2022, 17:24:54 UTC
Previous filing
08 Dec 2021
Next filing
16 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +20,318 $0.000000 20,318 12 Aug 2022 Common Stock 20,318 $17.47 Direct F1
transaction RCKT Restricted Stock Units Award $0 +28,763 $0.000000 28,763 12 Aug 2022 Common Stock 28,763 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 20,318 shares of the Issuer's common stock, which will become fully vested and exercisable on August 12, 2025.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 The restricted stock units will become fully vested on August 12, 2025.